Signifier Medical Technologies Reaches a Wider Patient Population with FDA Approval to Remove Dental Contraindications for eXciteOSA
Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, announces the FDA approval to remove dental contraindications for eXciteOSA. This opens the door for doctors and other providers to prescribe eXciteOSA on a more widespread basis.
Based on an observational study conducted by Signifier Medical, the data demonstrated no significant difference in the occurrence of eXciteOSA side effects amongst those with intraoral metal and those without intraoral metal dental work. As a result of these findings, the FDA has approved the removal of temporary or permanent metal implants, dental braces, and intraoral metal prosthesis, restorations, and appliances from contraindications. This meaningfully expands the number of patients who can benefit from a daytime therapy, with no nighttime wearable, for mild obstructive sleep apnea and snoring.
“It's a good thing when the FDA removes a barrier that didn't make sense to us as clinicians. The exclusion because of metal restorations made it more difficult to talk to non-dentist medical colleagues. Now, with the restriction lifted, we can go about finding the best therapy for the individual patient,” said Steve Carstensen, DDS, Co-founder of Premier Sleep Associates, the Director of Education for Airway Technologies, and Chief Dental Editor for Dental Sleep Practice Magazine.
In the study, Signifier gathered therapy experience data from 499 real-world users of eXciteOSA, including both civilian and Veteran patients. The focus of the study was primarily on the occurrence of side effects amongst patients with and without intraoral metal dental work and/or jewelry. Participants were asked to report the frequency, level of discomfort, and duration of eXciteOSA side effects. A thorough intraoral/dental history was obtained, focused on the presence of intraoral metal.
“A large number of Veterans were previously deemed ineligible for eXciteOSA for mild OSA/simple snoring because of the dental contraindications. This latest development is going to be well-received by VA clinics and patients across the country,” said Dr. Brandon Nokes, Director of Hypoglossal Nerve Stimulation at VA San Diego.
This study demonstrates the low-risk profile of eXciteOSA -- a novel medical therapy that was authorized in the FDA De Novo process. This important milestone moves eXciteOSA, which treats one of the root causes of OSA, one step closer to being a first-line therapy for millions of people suffering with mild sleep apnea and snoring.
About Signifier Medical Technologies
Signifier is a pioneer in addressing the root causes of sleep disordered breathing. The Company is focused on the development and commercialization of innovative and non-invasive solutions to help people breathe normally and naturally all night – without needing to use a wearable medical device or a surgical implant. Founded in 2015, Signifier is at the forefront of sleep therapy, with a mission to develop therapies to improve population health, increase the quality of patients’ healthcare experience, and generate healthcare savings. Signifier has offices in London (UK) and Needham (Massachusetts, USA).
About eXciteOSA
eXciteOSA is a revolutionary daytime therapy for sleep disordered breathing. Clinically proven to target a common root cause of OSA, eXciteOSA improves daytime sleepiness and sleep quality. Nearly one billion adults aged 30 to 69 years globally are estimated to suffer from OSA, which is a serious medical condition associated with health problems such as high blood pressure and increased risks of heart attack, stroke, or death.
A major underlying cause of OSA is reduced endurance of the upper airway muscles, allowing the tongue to fall back and block the upper airway. By using neuromuscular electrical stimulation (NMES) to “exercise” the upper airway muscles, eXciteOSA works the intrinsic and extrinsic tongue muscles to improve endurance and prevent airway collapse during sleep.
Unlike other devices which are used while patients sleep, eXciteOSA is the first commercially available device used while awake. The full benefits of the daytime therapy are realized without patient use during sleep.
Signifier is dedicated to engaging with the sleep research community to produce high-quality evidence from rigorous clinical trials. Randomized trials are in progress to understand the potential placebo effect (NCT04974515), the impact of therapy relative to usual care without treatment (NCT05183009; NCT05252156), and the impact of therapy amongst those with moderate OSA (NCT05252156).
To learn more about eXciteOSA, please visit www.signifiermedical.com or www.exciteosa.com.
For more information on the dental study, please email clinicaltrial@signifiermedical.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230222005880/en/
Contact information
Media:
Jay Cranston
Signifier Medical Technologies Inc
jay.c@signifiermedical.com
Investors and Partners:
Ekin Sezgen
Signifier Medical Technologies Inc
ekin.s@signifiermedical.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Great Hill Partners Expands Presence Internationally with Opening of London Office20.3.2023 12:00:00 EET | Press release
Great Hill Partners, a private equity firm that invests in high-growth, disruptive companies, today announced that the firm has opened a London office to support its strong historical track record of investment activity in the UK and Europe. The London office will serve as Great Hill’s regional hub for the UK and Europe, providing the firm with a dedicated local presence, greater access to investment opportunities, and resources for portfolio companies. Longtime Great Hill Managing Director Drew Loucks will lead the new office and grow the London team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230320005225/en/ (Photo: Business Wire) “Opening a London office is a natural next step for Great Hill," said Chris Gaffney, Managing Director at Great Hill. “We have more than a decade of experience investing in the UK and Europe, with a large and growing portfolio of international investments. The launch of a London office provi
Cirium Launches the First Airline Routes Tool Based on Satellite-Based Flight Tracking20.3.2023 11:00:00 EET | Press release
Cirium, the aviation analytics leader, has launched the aviation industry’s first Airline Routes tool to identify actual flights flown by aircraft type. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230320005187/en/ Cirium's Airline Routes tool analyzes an airline's routes using satellite-based flight tracking data to identify actual flights flown by aircraft type. (Photo: Business Wire) It uses applied analytics to derive routes flown by airlines based on satellite-based flight tracking and fuses this with advanced fleet data. The new premium Routes tool is part of Ascend Profiles, a visual descriptive analytics tool which enables businesses to quickly view aircraft intelligence by airline or lessor. Businesses such as aircraft lessors, banks or aircraft manufacturers are empowered to identify the aircraft flown by route for 1,700 airlines and factor development opportunities or risk into their decision making. By leveragi
2023 Harbin Ice & Snow Expo Was Successfully Held on March 17-1920.3.2023 10:55:00 EET | Press release
The 2023 Harbin Ice & Snow Expo, themed on "seeking development in the new paradigm and promoting the revitalization with ice and snow economy", was successfully held from 17 to 19 March in Harbin. It was hosted by Harbin Municipal People's Government, co-organized by CCPIT Harbin Committee and Beijing Zhenwei Exhibition Co., Ltd., and supported by Harbin Municipal Bureau of Culture, Radio, Television and Tourism. The Expo boasted a total exhibition area of 23,800 sqm, with 14 theme exhibition areas and nine international pavilions. Over 500 exhibitors in the ice-snow industry from 19 countries and regions, such as China, Canada, Iceland, France, Russia, Spain, etc., attended the event on online and offline platforms. Decathlon, POMA, Sany, XCMG, X-bionic, SUNAC SNOW PARK, HEILONG, Q.M.XUE LONG, Bombardier, Haxinlong Machinery, Fenlan Xuedong, Zhongcheng Technology, IWEIER STAR TECHNOLOGY, Ding Hongxin Sports Technology, TERROR, ADVANTURER and others showcased over 3,000 ice-snow exhib
Blackstone Announces Opening of New Office in Frankfurt, Germany20.3.2023 10:46:00 EET | Press release
Blackstone (NYSE: BX), the world’s largest alternative asset manager, today announced that it will open a new office in Frankfurt, Germany. The new flagship location will occupy 1,300 square meters in the OMNITURM in Frankfurt’s financial district and serve as a hub for Blackstone in Germany. The new office will host professionals across Blackstone’s private equity, real estate, and credit businesses, in addition to providing a hub for Blackstone’s private wealth solutions business, which serves investment professionals and individual investors across Europe. Juergen Pinker, Senior Managing Director, will lead on Private Equity, with Jurij Puth, Senior Managing Director, leading on Credit. Blackstone has been an active and significant investor in Germany for more than two decades, with currently more than 7,000 people employed by its portfolio companies in the country. To date, the firm has been involved in transactions worth more than €17 billion in Germany. The opening of the new off
Guardforce Security Adopts Hytera Push-to-talk to Improve Operational Efficiency20.3.2023 05:00:00 EET | Press release
Hytera Communications (SZSE: 002583), a leading global provider of professional communications technologies and solutions, has been providing Guardforce Security Thailand with its newest Push-to-Talk over Cellular (PoC) radios and Hytera HyTalk software suite to facilitate nationwide instant group communications and better team collaboration among Guardforce staff. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230314006104/en/ Guardforce security personnel on duty with Hytera PoC radios (Photo: Business Wire) Guardforce Thailand is a major security company that supplies technology-driven security solutions to a wide range of clients across Thailand, including banks, government organizations, retailers, shopping malls, hotels, airports, and enterprises. It currently employs approximately 5,000 security personnel nationwide across its three divisions. The security provider used to rely on analog two-way radios for communicati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom